Hospital
The New York and Presbyterian Hospital
The New York and Presbyterian Hospital was paid $1.72M by Medicaid between Jan 2020 and Oct 2024, across 66 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 15% of everything it billed.
33Billing provider infoTHE NEW YORK AND PRESBYTERIAN HOSPITAL
NEW YORK, NY 10032
NEW YORK, NY 10032
33aNPI1518061928assigned 09/08/2006
33bProvider typeRehabilitation Hospital
28Total paid$1.72M
24GClaims29,720
24DCodes billed66
24AFirst – last monthJan 2020 – Oct 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 2,332 | $120K | |
| 2021 | 4,759 | $244K | |
| 2022 | 8,861 | $478K | |
| 2023 | 11,214 | $683K | |
| 2024incomplete | 2,554 | $192K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 1,075 | 1,013 | $252K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 1,038 | 944 | $235K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 947 | 834 | $198K |
| G9005 | Coordinated care fee, risk adjusted maintenance | 11% | 483 | 483 | $187K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.7% | 641 | 572 | $132K |
| 87536 | 7.4% | 1,344 | 1,329 | $127K | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.8% | 609 | 559 | $117K |
| 96361 | Intravenous infusion, hydration; each additional hour | 5.2% | 255 | 236 | $89K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.1% | 1,536 | 920 | $54K |
| 80076 | 2.3% | 1,550 | 1,425 | $40K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.2% | 1,525 | 914 | $37K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.0% | 2,025 | 1,761 | $34K |
54 more codes
| 86356 | 1.4% | 587 | $23K | |
| 80053 | Comprehensive metabolic panel | 1.3% | 930 | $22K |
| 86360 | <1% | 735 | $16K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,818 | $16K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 62 | $15K |
| 86359 | <1% | 735 | $14K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 177 | $14K |
| 86355 | <1% | 660 | $14K | |
| 86357 | <1% | 660 | $13K | |
| 80061 | Lipid panel | <1% | 364 | $10K |
| 87486 | <1% | 194 | $8K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 154 | $7K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 254 | $6K |
| 90686 | <1% | 178 | $6K | |
| 88184 | <1% | 63 | $5K | |
| 87581 | <1% | 194 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 247 | $4K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 26 | $4K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 31 | $4K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 13 | $2K |
| 0124A | <1% | 29 | $1K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,522 | $1K |
| 0001A | <1% | 30 | $992.46 | |
| 0003A | <1% | 18 | $828.00 | |
| 86592 | <1% | 996 | $643.32 | |
| 91322 | <1% | 28 | $608.22 | |
| 0002A | <1% | 15 | $600.00 | |
| 90480 | <1% | 28 | $574.90 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 171 | $459.65 |
| 85610 | <1% | 97 | $426.12 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,079 | $315.26 |
| 86780 | <1% | 205 | $266.26 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 371 | $221.31 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 271 | $214.64 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 352 | $204.16 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 273 | $180.26 |
| 86593 | <1% | 223 | $138.46 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 14 | $115.52 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 199 | $110.16 |
| 86803 | <1% | 139 | $95.16 | |
| 81001 | <1% | 471 | $77.93 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 164 | $71.00 |
| 85027 | <1% | 180 | $55.92 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 15 | $18.40 |
| 84484 | <1% | 269 | $9.35 | |
| 83690 | <1% | 118 | $7.76 | |
| 85730 | <1% | 78 | $6.91 | |
| 80320 | <1% | 53 | $5.81 | |
| 83605 | 0% | 47 | $0.00 | |
| 82962 | 0% | 42 | $0.00 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 56 | $0.00 |
| 81003 | 0% | 13 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 12 | $0.00 |
| G1003 | Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBRESLIN, MIKE (CFO)
| Provider | Location | Paid |
|---|---|---|
| The New York and Presbyterian Hospital | New York, NY | $5.88M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.